Hyperhidrosis Treatment Market Share

Statistics for the 2023 & 2024 Hyperhidrosis Treatment market share, created by Mordor Intelligenceā„¢ Industry Reports. Hyperhidrosis Treatment share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Hyperhidrosis Treatment Industry

The hyperhidrosis treatment market is moderately competitive and consists of several major players. The prominent players in the market are AbbVie, Brickell Biotech, Eli Lilly and Company (Dermira), Advin Healthcare, and Dermavant Scienecs Inc. (Roivant Sci), among others. The companies operating in the market are focusing on R&D investments and fundraising activities to conduct clinical trials that lead to strong product pipelines.

Hyperhidrosis Treatment Market Leaders

  1. AbbVie Inc.

  2. Eli Lilly (Dermira)

  3. Advin Health Care

  4. Dermavant (Roivant Sciences)

  5. Brickell Biotech Inc.

*Disclaimer: Major Players sorted in no particular order

Hyperhidrosis Treatment Market _ CL_New.png

Hyperhidrosis Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)